Jinliang Yu - Publications

Tumor DNA from tumor in situ fluid was used to track evolution of glioma under first-line treatment.

Journal: Frontiers in oncology

Published: February 21, 2025

Efficacy and safety of endoscopic fenestration for treating giant middle cranial fossa arachnoid cysts in pediatrics.

Journal: Frontiers in pediatrics

Published: November 28, 2024

Dynamic Monitoring of Circulating Tumor DNA to Predict the Risk of Non In Situ Recurrence of Postoperative Glioma: A Prospective Cohort Study.

Journal: Cancer medicine

Published: March 16, 2024

Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 14, 2022

Real-time longitudinal analysis of human gliomas reveals in vivo genome evolution and therapeutic impact under standardized treatment.

Journal: Clinical and translational medicine

Published: April 02, 2022

Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients.

Journal: Journal of immunology research

Published: January 11, 2022

Tumor DNA From Tumor In Situ Fluid Reveals Mutation Landscape of Minimal Residual Disease After Glioma Surgery and Risk of Early Recurrence.

Journal: Frontiers in oncology

Published: July 15, 2021

Integrating real-time in vivo tumour genomes for longitudinal analysis and management of glioma recurrence.

Journal: Clinical and translational medicine

Published: June 21, 2021

Constrained-Spherical Deconvolution Tractography in the Evaluation of the Corticospinal Tract in Glioma Surgery.

Journal: Frontiers in surgery

Published: December 26, 2020

Characterizing the Genomic Landscape of Brain Glioma With Circulating Tumor DNA From Tumor In Situ Fluid.

Journal: Frontiers in oncology

Published: July 24, 2020